Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2025-12-25 @ 7:54 PM
Study NCT ID:
NCT02238535
Status:
UNKNOWN
Last Update Posted:
2015-09-23
First Post:
2014-09-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension
Sponsor:
Meshalkin Research Institute of Pathology of Circulation
Organization:
Study Overview
Official Title:
Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension
Status:
UNKNOWN
Status Verified Date:
2015-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the effectiveness of the synthetic analogue of prostacyclin in postembolic residual pulmonary hypertension.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: